Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Blood

• Publication date

  1990-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V75.12.2459.BLOODJOURNAL75122459PMID 2350582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.

  2009cited by this paper
• Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry.

  1989cited by this paper
• The clinical diagnosis of acute graft-versus-host disease: a diversity of views amongst marrow transplant centers.

  1988cited by this paper
• Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.

  1988cited by this paper
• Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials

  1988cited by this paper
• T cell depletion in bone marrow transplantation.

  1988cited by this paper
• Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma.

  1987cited by this paper
• The kinetics of immune reconstitution after human marrow transplantation.

  1987cited by this paper
• Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma

  1987cited by this paper
• Risk factors for acute graft‐versus‐host disease

  1987cited by this paper
• Autoantibody analysis of patients with graft versus host disease.

  1987cited by this paper
• Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease.

  1987cited by this paper
• Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.

  1986cited by this paper
• Female marrow donors increase the risk of acute graft‐versus‐host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum

  1986cited by this paper
• Acute and chronic graft-versus-host disease in man.

  1986cited by this paper
• An analysis of factors predisposing to chronic graft-versus-host disease.

  1985cited by this paper
• QUANTITATION OF T LYMPHOCYTES IN HUMAN BONE MARROW BY A LIMITING DILUTION ASSAY

  1985cited by this paper
• CYTOMEGALOVIRUS INFECTION ASSOCIATED WITH AND PRECEDING CHRONIC GRAFT‐VERSUS‐HOST DISEASE

  1984cited by this paper
• Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.

  1984cited by this paper
• [4] Graft-versus-host reactions

  1984cited by this paper
• Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.

  1983cited by this paper
• ACUTE AND CHRONIC GRAFT‐VERSUS‐HOST DISEASE INDUCED BY MINOR HISTOCOMPATIBILITY ANTIGENS IN MICE

  1983cited by this paper
• Sequential studies of cell inhibition of host fibroblasts in 51 patients given HLA-identical marrow grafts.

  1982cited by this paper
• Specific suppressor cells in graft–host tolerance of HLA-identical marrow transplantation

  1981cited by this paper
• Two distinct types of late onset graft-versus-host disease after bone marrow transplantation in lethally irradiated mice.

  1981cited by this paper
• Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

  1981cited by this paper
• In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance.

  1980cited by this paper
• Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease.

  1980cited by this paper
• Exponential relationship between spleen cell concentration and fatal graft-versus-host response after transplantation of allogeneic spleen-marrow cell mixtures.

  1980cited by this paper
• Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting.

  1979cited by this paper
• Chronic graft versus host disease: a syndrome of disordered immunity.

  1979cited by this paper
• Chronic cutaneous graft-versus-host disease in man.

  1978cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• A computer program for comparing K samples with right-censored data.

  1972cited by this paper
• Cellular immunology and the pathogenesis of graft versus host reactions.

  1971cited by this paper

• De novo and quiescent cGVHD are distinguishable in a prognostic biomarker panel.

  2026cites this paper
• Age-Related Considerations in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia: A 10-Year Retrospective Study

  2025cites this paper
• Whole-Blood Longitudinal Molecular Profiling Maps the Road of Graft Versus Host Disease (GVHD)

  2025cites this paper
• High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching

  2025influential citation
• A systematic review of treatments for cutaneous chronic graft-versus-host disease.

  2025cites this paper
• Use of Post-Transplant Cyclophosphamide in Matched Related and Unrelated Donor Hematopoietic Stem Cell Transplant for Benign Hematological Disorders

  2025cites this paper
• Intra-apheresis Cycling to Improve the Clinical Efficacy of Peripheral Blood Stem Cell Donations

  2025cites this paper
• Impact of underlying disease and total body irradiation on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation.

  2025cites this paper
• Ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in a pediatric population

  2025cites this paper
• Dental plaque microbiota following allogeneic hematopoietic cell transplantation and risk of chronic graft-versus-host disease

  2025cites this paper
• Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.

  2024cites this paper
• The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells

  2024cites this paper
• Graft Versus Host Disease: Management Issues in the Intensive Care Unit

  2024cites this paper
• Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model

  2024cites this paper
• Miliaria Crystallina Type Rash as an Unusual Presentation of Acute Graft Versus Host Disease (GVHD) After Hematopoietic Stem Cell Transplant’

  2024cites this paper
• Understanding and treatment of cutaneous graft-versus-host-disease

  2023cites this paper
• Reproductive late effects after hematopoietic stem cell transplant in pediatric, adolescent, and young adult cancer survivors

  2023cites this paper
• Survival and late mortality among patients who survived disease‐free for 2 years after stem cell transplantation

  2023cites this paper
• Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study

  2023cites this paper
• Chronic graft-versus-host disease in pediatric patients: Differences and challenges.

  2023cites this paper
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.

  2022cites this paper
• Noncoding RNAs in diagnosis and prognosis of graft‐versus‐host disease (GVHD)

  2022cites this paper
• A bibliometric analysis of global publications on graft-versus-host disease research

  2022cites this paper
• Graft-Versus-Host Disease (GvHD) Prophylaxis

  2021cites this paper
• Ecto-5′nucleotidase (CD73) May Predict Occurrence and Grade of GVHD in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

  2021cites this paper
• A Case Report of Central Nervous System Graft-Versus-Host Disease and Literature Review

  2021cites this paper
• Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance

  2021cites this paper
• Graft Versus Host Disease: Management of Acute and Chronic Disease

  2020cites this paper
• Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models.

  2020cites this paper
• Review of Graft-Versus-Host Disease.

  2019cites this paper
• Clinical aspects of chronic graft-versus-host disease

  2019cites this paper
• Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies.

  2019cites this paper
• Hematopoietic Stem Cell Transplant and Cellular Therapy

  2019cites this paper
• Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis

  2019cites this paper
• Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia

  2019cites this paper
• Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.

  2019cites this paper
• Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation

  2018cites this paper
• Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting

  2018cites this paper
• What is the outcome in patients with acute leukaemia who survive severe acute graft‐versus‐host disease?

  2018cites this paper
• Chronic graft-versus-host disease: Current management paradigm and future perspectives.

  2018cites this paper
• Outcomes of matched sibling donor bone marrow transplantation in children using single‐agent calcineurin inhibitors as prophylaxis for graft versus host disease

  2018cites this paper
• Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.

  2018cites this paper
• Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention

  2017cites this paper
• Complications and Results

  2017cites this paper
• Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.

  2017cites this paper
• Dermal and Subcutaneous Chronic Graft-Versus-Host Disease

  2017cites this paper
• The challenge of co-existence : from graft-versus-host disease to stable mixed chimerism after allogeneic hematopoietic stem cell transplantation

  2017cites this paper
• Pediatric Graft-Versus-Host Disease

  2017cites this paper
• FLT3‐ITD mutations do not impact the outcome of patients allografted with partial T‐cell depleted grafts for AML with normal cytogenetics in first complete remission

  2017cites this paper
• Diagnostic considerations for cholestatic liver disease

  2017cites this paper
• The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD Following Hematopoietic Stem Cell Transplantation

  2017cites this paper
• Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment

  2017cites this paper
• DC 2 Effect on Survival Following Allogeneic Bone Marrow Transplantation

  2017cites this paper
• Hematopoietic cell transplantation for aplastic anemia

  2017cites this paper
• Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease

  2017cites this paper
• Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation

  2016cites this paper
• A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.

  2016cites this paper
• Hosting an Unruly Guest: The Impact of Late Acute and Chronic Graft-versus-Host Disease.

  2016cites this paper
• Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

  2016cites this paper
• Selecting the best haploidentical donor.

  2016cites this paper
• High Risk of Chronic Graft-Versus-Host Disease in Unmanipulated Allogeneic Peripheral Blood Stem Cell Transplantation

  2016cites this paper
• Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome

  2016cites this paper
• Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups

  2016influential citation
• Current state and perspectives of stem cell therapy for stroke

  2016cites this paper
• Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.

  2016influential citation
• Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

  2016cites this paper
• Tacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantation

  2016cites this paper
• Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation

  2016cites this paper
• Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis

  2015cites this paper
• High pre-transplant TREC levels indicate good prognosis after hematopoietic stem cell transplantation

  2015cites this paper
• Elevated level of HSPA1L mRNA correlates with graft-versus-host disease.

  2015cites this paper
• Identification and validation of biomarkers associated with acute and chronic graft versus host disease

  2015cites this paper
• Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long‐term outcome

  2015influential citation
• Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation

  2015cites this paper
• Динамическое наблюдение детей после аллогенной трансплантации гемопоэтических стволовых клеток

  2015cites this paper
• Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

  2015cites this paper
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

  2015cites this paper
• Mesenchymale Stromazellen bei der Therapie der Graft-versus-Host-Erkrankung: Wo stehen wir?

  2015cites this paper
• Hematopoietic Stem Cell Transplant

  2015cites this paper
• Graft-Versus-Host-Disease nach NIH-Klassifikation bei Patienten mit Akuter Lymphatischer Leukämie: Klinische Präsentation, Prognostische Relevanz und Nachweis eines Potenten Graft-Versus-Leukämie-Effekts

  2015cites this paper
• Decreased Risk of Acute Graft-versus-Host Disease Using Reduced Intensity Conditioning Compared to Myeloablative Conditioning is Independent of Donor-Recipient T-cell Chimerism

  2014cites this paper
• Regulatory T cells in haematopoietic stem cell transplantation

  2014cites this paper
• Fludarabine, cytarabine, granulocyte colony‐stimulating factor and melphalan (FALG with L‐PAM) as a reduced toxicity conditioning regimen in children with acute leukemia

  2014cites this paper
• Who Is the Best Hematopoietic Stem-Cell Donor for a Male Patient With Acute Leukemia?

  2014cites this paper
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

  2014cites this paper
• Achievement of Transplantation Tolerance: Novel Approaches and Mechanistic Insights

  2014cites this paper
• Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome—results from a large single-center study

  2014influential citation
• Chronic graft versus host disease and nephrotic syndrome.

  2014cites this paper
• Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation

  2014cites this paper
• Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease

  2014cites this paper
• Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.

  2013cites this paper
• siblings with standard-risk leukemia Transplantation of mobilized peripheral blood cells to HLA-identical

  2013cites this paper
• The genetic and functional significance of non-HLA polymorphisms in haematopoietic stem cell transplantation

  2013cites this paper
• ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE

  2013cites this paper
• The role of B cells in the pathogenesis of chronic graft-versus-host disease

  2013cites this paper
• Magnetic Resonance imaging for Chronic Graft-versus-host- disease-related Myositis and Fasciitis: a Rare Complication of Stem Cell t ransplantation

  2013cites this paper
• TRANSPLANTATION Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

  2013cites this paper
• Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus-Host Disease and Graft Failure After Hematopoietic Stem Cell Transplantation and Future Challenges

  2013cites this paper
• graft-versus-host disease Recipient CD4+ T cells that survive irradiation regulate chronic

  2013cites this paper
• Graft-Versus-Host Disease

  2013cites this paper